Global investment firm KKR has pulled out of a deal to take a majority stake in Spain’s biggest dental chain, Dentix, the company exclusively tells HBI. It is KKR's second high-profile decision not to invest in a large healthcare group this week.
European nursing home operator DomusVi has acquired two facilities in Chile through its subsidiary Acalis as part of a rapid expansion strategy across the region. This is the group's second acquisition in Latin America, as growth has otherwise been focused on greenfield. We speak to the CEO of Acalis Latam about the group's regional strategy.
Europe's third-largest nursing home group by revenue, DomusVi, has appointed a new CEO with no healthcare services management experience. He is the group's third CEO in the space of a year.
Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis.
Panellists on the LatAm panel at HBI 2019 see good opportunities in the region thanks to booming demand, particularly as demographics shift from rural to urban bases, and with the growth of the chronic and elderly care markets. Increasing use of digital health tools and better data, plus the growth of the consumer market are also seen as positive factors for the market.
Why did Bupa, the international health insurer which is also one of the largest health care service players outside of the USA, announce its 2018 results so quietly that HBI isn't aware of any UK daily reporting them this year? The figures show that Bupa's £3.37bn of revenue from nursing homes, hospitals, dentistry and primary care across a dozen countries, barely made money. Could this be down to its interesting governance structure?
Orpea, Europe's second-largest nursing home operator by revenue, has made big strides in Latin America, with acquisitions in Chile, Brazil and Uruguay in 2018. We speak to a market expert about its expansion, with a focus on Brazil, and its full-year results published this week.
Javier Echevarria, CEO, Europe and LatAm of Veritas International (VI) has one of the most interesting challenges in marketing - how do you persuade wealthy consumers to spend around $2,000 on predictive whole genome sequencing (WGS)? He has a broad canvas - his remit is to sell across LatAm, UAE, Europe and Japan.
Universal Health Coverage is one of the UN's Sustainable Development Goals and it's expected to be completed by 2030. But a newly released report argues that a lack of PPPs is stalling that goal. Healthcare Nova looks at the key findings...
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy